Hermes Garbán
Keine laufenden Positionen mehr
Profil
Hermes D.
Garbán worked as a Professor at the University of California, Los Angeles from 2005 to 2014.
He was also a Principal Investigator at The California NanoSystems Institute.
From 2014 to 2019, he worked at Nantbio, Inc. as the Head of Therapeutics Discovery & Development.
In 2017, he became the Deputy VP-Global Cell Manufacturing at NantKwest, Inc. He also worked as the Head of Therapeutics Discovery & Development at NantCell, Inc. In 2019, he joined ImmunityBio, Inc. as the Head of Therapeutics Discovery & Development until 2021.
In 2021, he became the Chief Medical Officer at Vincerx Pharma, Inc. Dr. Garbán holds a doctorate degree from the University of California, Los Angeles, Central University of Venezuela, and the University of California.
Ehemalige bekannte Positionen von Hermes Garbán
| Unternehmen | Position | Ende |
|---|---|---|
| VINCERX PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2022 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01.02.2021 |
Nantbio, Inc.
 Nantbio, Inc. Pharmaceuticals: MajorHealth Technology Nantbio, Inc. is a biopharmaceutical company that develops molecular drugs. The company is based in El Segundo, CA. The CEO of the company is Patrick Soon-Shiong. | Corporate Officer/Principal | 01.03.2019 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01.10.2018 |
| University of California, Los Angeles | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Hermes Garbán
| University of California, Los Angeles | Doctorate Degree |
| Central University of Venezuela | Doctorate Degree |
| University of California | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VINCERX PHARMA, INC. | Health Technology |
| IMMUNITYBIO, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
Nantbio, Inc.
Nantbio, Inc. Pharmaceuticals: MajorHealth Technology Nantbio, Inc. is a biopharmaceutical company that develops molecular drugs. The company is based in El Segundo, CA. The CEO of the company is Patrick Soon-Shiong. | Health Technology |
NantCell, Inc.
 NantCell, Inc. Pharmaceuticals: MajorHealth Technology NantCell, Inc. focuses on treating immunology diseases. It offers cell-based treatments at the molecular level. The firm develops molecularly designed drugs for genomics and proteomics and identify patients and their tumor signature at the granular cellular, DNA and protein levels. The company was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA. | Health Technology |
